List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 215 studies with search of: spasticity
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed
Has Results 		A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
2 Completed Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Conditions: Spasticity;   Cerebral Palsy
Intervention: Drug: baclofen
3 Completed Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity
Condition: Muscle Spasticity
Intervention: Drug: Tizanidine (sublingual or oral)
4 Withdrawn Continuous Intrathecal Baclofen Infusion for Chronic Spasticity
Condition: Spasticity
Intervention: Device: Prometra Programmable Implantable Pump System
5 Completed Vanderbilt University Spasticity Management Program Evaluation Plan
Condition: Spasticity
Interventions: Drug: Botulinum Toxin Type A;   Drug: Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB)
6 Active, not recruiting A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
Condition: Spasticity
Intervention:
7 Completed
Has Results 		Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
8 Recruiting Retrospective Study of Patients With Spasticity in the Spanish Population
Condition: Muscle Spasticity
Intervention: Other: No treatment
9 Completed MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A;   Drug: Botulinum Toxin type A
10 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Condition: Muscle Spasticity
Interventions: Drug: tolperisone HCl (AV650);   Drug: Placebo
11 Completed The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Intervention: Procedure: Penile Vibratory Stimulation
12 Completed A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
13 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Condition: Muscle Spasticity
Intervention: Drug: tolperisone HCl
14 Recruiting Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication
15 Completed Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
Intervention:
16 Completed Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
Conditions: Muscle Spasticity;   Cerebrovascular Accident
Interventions: Drug: Botulinum toxin type A (Dysport®);   Other: Placebo
17 Completed Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Conditions: Mental Retardation;   Spasticity
Intervention:
18 Completed Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
Condition: Focal Upper Limb Spasticity
Interventions: Drug: Botulinum toxin type A, BoNT-A;   Other: Rehabilitation Therapy
19 Completed A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity
Condition: Spasticity, Post-Stroke
Intervention: Drug: Botulinum toxin type A
20 Completed
Has Results 		A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity
Conditions: Cerebrovascular Accident;   Spasticity, Post-Stroke
Interventions: Drug: Botulinum toxin type A;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services